STOCK TITAN

Director awarded 100,000 Streamex (STEX) shares under 2023 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Marciano Anthony Mark reported acquisition or exercise transactions in this Form 4 filing.

Streamex Corp. director Marciano Anthony Mark received a grant of 100,000 shares of common stock as a restricted stock award on February 23, 2026. The award was issued under Streamex’s 2023 Equity Incentive Plan at no purchase price, using a $2.15 closing share price for valuation.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Marciano Anthony Mark

(Last) (First) (Middle)
C/O STREAMEX CORP.
2431 ALOMA AVE STE 243

(Street)
WINTER PARK FL 32792

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Streamex Corp. [ STEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/23/2026 A 100,000 A $0(1) 100,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The restricted stock award was granted under the Issuer's 2023 Equity Incentive Plan as of February 23, 2026, based on a closing price of $2.15 per share on such date.
/s/ Anthony Marciano 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Streamex Corp. (STEX) report in this Form 4?

Streamex Corp. reported that director Marciano Anthony Mark received a grant of 100,000 shares of common stock. The award is in the form of restricted stock issued under the company’s 2023 Equity Incentive Plan on February 23, 2026, at no purchase price.

How many Streamex Corp. (STEX) shares did the director acquire and at what price?

The director acquired 100,000 shares of Streamex Corp. common stock in a grant transaction priced at $0.00 per share. For valuation purposes, the award was based on Streamex’s closing market price of $2.15 per share on February 23, 2026.

What type of equity award did Streamex Corp. (STEX) grant to its director?

Streamex Corp. granted its director a restricted stock award consisting of 100,000 shares of common stock. The award was issued under the company’s 2023 Equity Incentive Plan and represents a non-cash acquisition rather than an open-market stock purchase.

Under which plan was the Streamex Corp. (STEX) stock award to the director granted?

The stock award to the Streamex Corp. director was granted under the company’s 2023 Equity Incentive Plan. This plan provides a framework for equity-based compensation, and the reported transaction reflects a restricted stock grant of 100,000 shares on February 23, 2026.

Did the Streamex Corp. (STEX) director buy the shares on the open market?

No, the Streamex Corp. director did not buy these shares on the open market. The Form 4 shows a grant transaction coded as an award acquisition, meaning 100,000 restricted shares were issued as compensation under the 2023 Equity Incentive Plan at no cash cost.
BioSig Technologies Inc

NASDAQ:BSGM

BSGM Rankings

BSGM Latest News

BSGM Latest SEC Filings

BSGM Stock Data

156.96M
25.09M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
WESTPORT